ConductScience.org, home

Paper41353403

Glycogen synthase kinase-3 activation and dysregulation of amyloid transport receptors expression and shedding in HIV-induced Alzheimer's disease-like pathology: modulatory effects of CCR5 antagonists.

Bhargavan B and 2 others. Acta Neuropathol Commun, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Glycogen synthase kinase-3 activation and dysregulation of amyloid transport receptors expression and shedding in HIV-induced Alzheimer's disease-like pathology: modulatory effects of CCR5 antagonists. Papers, record 41353403. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41353403

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glycogen synthase kinase-3 activation and dysregulation of amyloid transport receptors expression and shedding in HIV-induced Alzheimer's disease-like pathology: modulatory effects of CCR5 antagonists.
PubMed
Journal
Acta Neuropathol Commun
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-12
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bhargavan BBiju
2Annadurai NNarendran
3Kanmogne GDGeorgette D

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Glycogen Synthase Kinase 3Major topic
CCR5 Receptor AntagonistsMajor topic
Receptors, CCR5Major topic
HIV InfectionsMajor topic
Humans
Animals
Amyloid beta-Peptides
Low Density Lipoprotein Receptor-Related Protein-1
Brain
tau Proteins
Maraviroc
Mice
Receptor for Advanced Glycation End Products
Endothelial Cells
Disease Models, Animal
Peptide Fragments
Mice, Transgenic
Phosphorylation

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 MH132517NIMH NIH HHSUnited StatesR01MH132517PubMed and NIHNIH RePORTER
R21 MH123303NIMH NIH HHSUnited StatesR21MH123303PubMed and NIHNIH RePORTER
1R21 MH123303 and 1R01 MH132517NIMH NIH HHSUnited StatesR21MH123303PubMed and NIHNIH RePORTER

Download CSV of grants

References139

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117989287Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments.J Neurosci2007https://conductscience.org/library/papers/17989287PubMed
228381441Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies.J Lipid Res2017https://conductscience.org/library/papers/28381441PubMed
317241269Glycogen synthase kinase-3 inhibition is integral to long-term potentiation.Eur J Neurosci2007https://conductscience.org/library/papers/17241269PubMed
423173075Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo.ACS Chem Neurosci2012https://conductscience.org/library/papers/23173075PubMed
526491256Maraviroc: a review of its use in HIV infection and beyond.Drug Des Devel Ther2015https://conductscience.org/library/papers/26491256PubMed
624904272GSK-3β, a pivotal kinase in Alzheimer disease.Front Mol Neurosci2014https://conductscience.org/library/papers/24904272PubMed
79735171Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.Arch Biochem Biophys1998https://conductscience.org/library/papers/9735171PubMed
834729690Neuropathology of Alzheimer's Disease.Neurotherapeutics2022https://conductscience.org/library/papers/34729690PubMed
925205593Amyloid-β efflux from the central nervous system into the plasma.Ann Neurol2014https://conductscience.org/library/papers/25205593PubMed
1016905787Biology of CCR5 and its role in HIV infection and treatment.JAMA2006https://conductscience.org/library/papers/16905787PubMed
1115882940RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling.Biochim Biophys Acta2005https://conductscience.org/library/papers/15882940PubMed
1226945343Elevation and persistence of CD8 T-cells in HIV infection: the Achilles heel in the ART era.J Int AIDS Soc2016https://conductscience.org/library/papers/26945343PubMed
1321514616Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors.Virology2011https://conductscience.org/library/papers/21514616PubMed
1421629738GSK-3 in Neurodegenerative Diseases.Int J Alzheimers Dis2011https://conductscience.org/library/papers/21629738PubMed
159225683Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities.Ann Neurol1997https://conductscience.org/library/papers/9225683PubMed
1618089847Identification, classification, and expression of RAGE gene splice variants.FASEB J2008https://conductscience.org/library/papers/18089847PubMed
1715155381RAGE axis: Animal models and novel insights into the vascular complications of diabetes.Arterioscler Thromb Vasc Biol2004https://conductscience.org/library/papers/15155381PubMed
1826965674HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.Nat Rev Neurol2016https://conductscience.org/library/papers/26965674PubMed
1928012947The GSK-3-inhibitor VP2.51 produces antidepressant effects associated with adult hippocampal neurogenesis.Neuropharmacology2017https://conductscience.org/library/papers/28012947PubMed
2019371428LRP1 shedding in human brain: roles of ADAM10 and ADAM17.Mol Neurodegener2009https://conductscience.org/library/papers/19371428PubMed

See all 139 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42071213The meningeal lymphatic vessel-peripheral immune axis: a novel therapeutic target in neurodegenerative diseases.J Neuroinflammation2026https://conductscience.org/library/papers/42071213

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41353403

GET https://conductscience.org/api/papers/v1/41353403/references?page=2